중국의 혈액 질환 치료제에 대한 수요는 지난 10년간 빠른 속도로 증가했습니다. 향후 10년 동안 생산과 수요는 모두 계속 증가할 것입니다. 중국 경제는 20년 이상 산업 생산, 수출입, 소비자 소비, 자본 투자의 지속적인 증가에 힘입어 고속 성장을 유지하고 있습니다.
이 보고서는 중국의 혈액 질환 치료제 시장에 대해 조사했으며, 중국의 경제 동향, 투자 환경, 산업 발전, 수요와 공급, 산업 역량, 산업 구조, 마케팅 채널 및 주요 산업 참여자를 조사합니다. 과거 데이터(2014년, 2019년, 2024년)와 2029년 및 2034년까지의 장기 예측이 제시됩니다. 중국의 주요 생산업체가 프로파일링되어 있습니다.
목차
제1장 서론
제2장 비즈니스 환경
경제 전망
주요 경제 지표
산업 생산
인구와 노동
외국인 투자
무역
금융 및 세무 규제
은행 시스템과 규제
외환
세금, 관세, 통관 수수료
제3장 혈액 질환 치료제 업계의 평가
혈액 질환 치료제 업계의 구조
시장 규모
시장 성장의 원동력
혈액 질환 치료제 판매량
주요 생산 시설의 소재지와 판매량
주요 생산 업체 시장 점유율
인건비
잠재적인 참가자
주요 유통업체
주요 외국인 투자
기술 개발
제4장 혈액 질환 치료제의 생산과 수요
개요
지역별 혈액 질환 치료제 수요
혈액 질환 치료제 판매량
빈혈 치료제
메코발라민
코바마미드
숙신산철
백혈구원
호중구 감소증 및 무과립구증 치료제
비타민 B4
바티롤
이노신
데옥시리보뉴클레오티드
부신피질호르몬
과립구 콜로니 자극 인자(G-CSF)
백혈병 치료제 판매량
인터페론
이마티닙
리툭시맙
피랄 비신
히드록시캄포테신
기타 혈액 질환 치료제의 판매량
혈액 질환 치료제의 수입
빈혈 치료제
메코발라민
코바마미드
숙신산철
백혈구원
호중구감소증 및 무과립구증 치료제의 수입
비타민 B4
바티롤
이노신
데옥시리보뉴클레오티드
부신피질호르몬
과립구 콜로니 자극 인자(G-CSF)
백혈병 치료제의 수입
인터페론
이마티닙
리툭시맙
피랄 비신
히드록시캄포테신
기타 혈액 질환 치료제의 수입
가격 동향
제5장 혈액 질환 치료제 시장 전망
혈액 질환 치료제 시장 전망 개요
정부의 규제
의료 보험 업계의 개요
소비자 지출 동향
의료 산업 동향
병원 및 병원 병상
제6장 마케팅 전략
중국 시장 진입의 개요
중국의 유통 시스템
고무 가공 화학 제품 유통 채널
운송 및 화물 인프라
통신
중국 시장 진입
라이선싱
프랜차이즈
전자상거래
무역 회사 및 현지 대리점
주재원 사무소 및 중국 자회사
외국인 소유 기업
제7장 혈액 질환 치료제 제조자 목록
제1장 서론
경제 전망의 개요
제2장 비즈니스 환경
주요 경제 지표
산업 생산
인구와 노동력의 동향
외국인투자와 대출
무역
제3장 혈액 질환 치료제 업계의 평가
제4장 혈액 질환 치료제의 생산과 수요
제5장 혈액 질환 치료제 시장 전망
HBR
영문 목차
영문목차
China's demand for Blood Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2014, 2019 and 2024) and long-term forecasts through 2029 and 2034 are presented. Major producers in China are profiled.
The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.
Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.
TABLE OF CONTENTS
I. INTRODUCTION
Report Scope and Methodology
Executive Summary
II. BUSINESS ENVIRONMENT
Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
Blood Disease Drugs Industry Structure
Market Size
Market Growth Drivers
Blood Disease Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Overview
Demand of Blood Disease Drugs by Region
Blood Disease Drugs Sales Volume
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Sales Volume
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Sales Volume
Blood Disease Drugs Imports
Anemia Treatment Drugs
Mecobalamin
Cobamamide
Ferrous Succinate
Leucogen
Neutropenia and Agranulocytosis Treatment Drugs Imports
VitamineB4
Batilol
Inosine
Deoxyribonucleotide
Adrenocortical Hormone
Granulocyte Colony-Stimulating Factor(G-CSF)
Leukemia Treatment Drugs Imports
Interferon
Imatinib
Rituximab
Pirarubicin
Hydroxycampothecin
Other Blood Disease Drugs Imports
Pricing Trends
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
Blood Disease Drugs Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Northeast
North
Southeast
Central
Southwest
Northwest
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
VI. MARKETING STRATEGIES
China Market Entry Overview
China's Distribution System
Rubber Processing Chemicals Distribution Channels
Transportation and Freight Infrastructure
Communications
China's Market Entry
Licensing
Franchising
E-commerce
Trading Companies and Local Agents
Representative Offices and Chinese Subsidiaries
Wholly Foreign Owned Enterprises
VII. BLOOD DISEASE DRUGS PRODUCER DIRECTORY
Blood Disease Drugs Producer Profiles
Distributors and Trading Companies
Research Institutions and Associations
ULIST OF TABLES
I. INTRODUCTION
Economic Outlook Summary
II. BUSINESS ENVIRONMENT
Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade
III. BLOOD DISEASE DRUGS INDUSTRY ASSESSMENTS
Anemia Treatment Drugs Sales Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Blood Disease Drugs Sales Volume
Major Producer Facility Location
Major Blood Disease Drugs Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China
IV. BLOOD DISEASE DRUGS PRODUCTION AND DEMAND
Total Blood Disease Drugs Sales Volume
Blood Disease Drugs Major Producer and Their Market Share
Anemia Major Producer and Their Market Share
Anemia Treatment Drugs Sales Volume by Drugs Classification
Anemia Treatment Drugs Major Producer and Their Market Share
Mecobalamin Major Producer and Their Market Share
Cobamamide Major Producer and Their Market Share
Ferrous Succinate Major Producer and Their Market Share
Leucogen Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Major Producer and Their Market Share
Neutropenia and Agranulocytosis Treatment Drugs Sales Volume by Drugs Classification
VitamineB4 Major Producer and Their Market Share
Batilol Major Producer and Their Market Share
Inosine Major Producer and Their Market Share
Deoxyribonucleotide Major Producer and Their Market Share
Adrenocortical Hormone Major Producer and Their Market Share
Granulocyte Colony-Stimulating Factor(G-CSF) Major Producer and Their Market Share
Leukemia Treatment Drugs Major Producer and Their Market Share
Leukemia Treatment Drugs Sales Volume by Drugs Classification
Interferon Major Producers and Their Market Share
Imatinib Mesylate Major Producer and Their Market Share
Rituximab Major Producer and Their Market Share
Pirarubicin Major Producer and Their Market Share
Hydroxycampothecin Major Producer and Their Market Share
Blood Disease Drugs Import
Anemia Treatment Drugs Import Volume by Drugs Classification
Neutropenia and Agranulocytosis Treatment Drugs Import Volume by Drugs Classification
Leukemia Treatment Drugs Import Volume by Drugs Classification
V. BLOOD DISEASE DRUGS MARKET OUTLOOK
Consumer Spending Trend
The Structure of Per Capita Expenditure in the Northeast of China
The Structure of Per Capita Expenditure in the North of China
The Structure of Per Capita Expenditure in the Southeast of China
The Structure of Per Capita Expenditure in the Central of China
The Structure of Per Capita Expenditure in the Southwest of China
The Structure of Per Capita Expenditure in the Northwest of China
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
(주)글로벌인포메이션02-2025-2992kr-info@giikorea.co.kr ⓒ Copyright Global Information, Inc. All rights reserved.
